Adjuvance Technologies, Inc.
1 clinical trials · Sponsor
◉ Watch Adjuvance Technologies, Inc.
| Record | Firm | Date |
|---|---|---|
| Pertussis Acellular Vaccine Adjuvanted With TQL1055 (NCT04793620) | Adjuvance Technologies, Inc. | 2021-04-06 |
Track Adjuvance Technologies, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.